SlideShare una empresa de Scribd logo
1 de 16
Normalization of Delayed GastricNormalization of Delayed Gastric
Emptying after Treatment forEmptying after Treatment for
Bulimia NervosaBulimia Nervosa
Janet L. Guss, BT Walsh, HR Kissileff, EJanet L. Guss, BT Walsh, HR Kissileff, E
Zimmerli, R Sysko & MJ DevlinZimmerli, R Sysko & MJ Devlin
Obesity Research CenterObesity Research Center
Columbia UniversityColumbia University
Patients with Bulimia Nervosa (BN) have aPatients with Bulimia Nervosa (BN) have a
disturbance in the development of satiety:disturbance in the development of satiety:
Episodes of uncontrolled hyperphagiaEpisodes of uncontrolled hyperphagia
Rates of eating do not decline as meal progressesRates of eating do not decline as meal progresses
More food required to increase ratings of fullnessMore food required to increase ratings of fullness
Blunted post-prandial cholecystokinin (CCK) releaseBlunted post-prandial cholecystokinin (CCK) release
Gastric Emptying may be delayed in BN:Gastric Emptying may be delayed in BN:
Authors Delayed Emptying?Authors Delayed Emptying? CommentsComments
Shih et al, 1987Shih et al, 1987 Yes (12/20) other 8/20 acceleratedYes (12/20) other 8/20 accelerated
Robinson et al, 1988Robinson et al, 1988 No (1/10)No (1/10)
Cuellar et al, 1988Cuellar et al, 1988 Yes (2/5)Yes (2/5) only pts with GI symptomsonly pts with GI symptoms
Hutson & Wald, 1990Hutson & Wald, 1990 NoNo
Geliebter et al, 1992Geliebter et al, 1992 Yes /NoYes /No only @ 5 & 15 minonly @ 5 & 15 min
Inui et al, 1995Inui et al, 1995 YesYes small number of subjectssmall number of subjects
Devlin et al, 1997Devlin et al, 1997 Yes/NoYes/No delayed in 1 of 3 conditionsdelayed in 1 of 3 conditions
HypothesisHypothesis
Satiety disturbances in patients with BN maySatiety disturbances in patients with BN may
be perpetuated by delayed gastric emptyingbe perpetuated by delayed gastric emptying
Delayed emptying may blunt nutrient-Delayed emptying may blunt nutrient-
triggered release of gut peptides, such astriggered release of gut peptides, such as
CCK, that normally bring about satiationCCK, that normally bring about satiation
PurposePurpose
Confirm previous reports of delayed gastricConfirm previous reports of delayed gastric
emptying among patients with BNemptying among patients with BN
Determine whether disturbance normalizesDetermine whether disturbance normalizes
after cessation of binge & purge behaviorsafter cessation of binge & purge behaviors
ProcedureProcedure
Subjects:Subjects:
16 patients meeting DSM-IV criteria for BN16 patients meeting DSM-IV criteria for BN
16 demographically-matched controls16 demographically-matched controls
9 of the 16 patients retested, if they abstained from9 of the 16 patients retested, if they abstained from
bulimic behaviors for at least 4 weeksbulimic behaviors for at least 4 weeks
Procedure:Procedure:
Emptying ofEmptying of 99m99m
TcDTPA-labeled Ensure Plus (600g, 950TcDTPA-labeled Ensure Plus (600g, 950
kcal) monitored via gamma scintigraphykcal) monitored via gamma scintigraphy
Counts collected at 2-min intervals for 90 minutesCounts collected at 2-min intervals for 90 minutes
Counts determined within defined region of interestCounts determined within defined region of interest
(ROI) and converted to percentage of maximum counts(ROI) and converted to percentage of maximum counts
Experimental TimelineExperimental Timeline
PositionPosition
SSubjectubject
StartStart
GammaGamma
CameraCamera
600 g600 g
EnsureEnsure
PlusPlus
Stop GammaStop Gamma
CameraCamera
Radioactive counts acquired every 2 min for 90 min
PositionPosition
SubjectSubject
Subject Characteristics:Subject Characteristics: (Mean(Mean  SE)SE)
ControlsControls PatientsPatients
nn 1616 1616
Age (yrs)Age (yrs) 26.826.8 ±± 1.01.0 24.224.2 ±± 1.11.1
Weight (kg)Weight (kg) 62.262.2 ±± 1.51.5 59.459.4 ±± 1.91.9
Height (m)Height (m) 1.71.7 ±± 0.020.02 1.61.6 ±± 0.020.02
BMI (kg/m2)BMI (kg/m2) 21.721.7 ±± 0.40.4 22.122.1 ±± 0.70.7
Clinical Characteristics (MeanClinical Characteristics (Mean  SE)SE)
ControlsControls PatientsPatients DifferenceDifference
RestraintRestraint 6.56.5  5.75.7 13.713.7  4.74.7 p<.005p<.005
DisinhibitionDisinhibition 3.03.0  1.11.1 13.313.3  2.02.0 p<.001p<.001
HungerHunger 3.53.5  2.02.0 10.010.0  3.33.3 p<.001p<.001
Duration (yrs)Duration (yrs) ---- 11.311.3  7.57.5
Binges/wkBinges/wk ---- 18.218.2  27.727.7
Vomiting/wkVomiting/wk ---- 20.420.4  17.717.7
Data AnalysisData Analysis
Patients versus Controls: t-testsPatients versus Controls: t-tests
Amount emptied (g) over 90 minutesAmount emptied (g) over 90 minutes
Rate (g/min)Rate (g/min)
Patients, Pre versus Post Treatment: paired t-testsPatients, Pre versus Post Treatment: paired t-tests
Amount emptied over 90 minutesAmount emptied over 90 minutes
Rate (g/min)Rate (g/min)
Gastric Emptying: Patients vs ControlsGastric Emptying: Patients vs Controls
Time (min)
0 10 20 30 40 50 60 70 80 90
PercentofInitialRemaining
40
50
60
70
80
90
100
Bulimia Nervosa
Controls
Gastric Emptying: Pre vs Post Treatment
Time (min)
0 10 20 30 40 50 60 70 80 90
PercentageofInitialRemaining
40
50
60
70
80
90
100
Pretreatment
Post-treatment
Amount Emptied over 90 MinutesAmount Emptied over 90 Minutes
Bulimic Control Pre-Tx Post-Tx
AmountEmptied(g)
0
50
100
150
200
250
300
350
Patients
v p < 0.001
P < 0.001P < 0.001 P < 0.01P < 0.01
Bulimic Control Pre-Tx Post-Tx
EmptyingRate(g/min)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
Patients
Gastric Emptying Rate (g/min)Gastric Emptying Rate (g/min)
P < 0.01P < 0.01
P < 0.05P < 0.05
SummarySummary
Patients with BN exhibited reducedPatients with BN exhibited reduced
gastric emptying which improvedgastric emptying which improved
significantly after termination ofsignificantly after termination of
binge/purge activitybinge/purge activity
ConclusionsConclusions
Normalization of gastricNormalization of gastric
emptying mayemptying may mediatemediate,,
oror be mediated bybe mediated by, a, a
return to normalizedreturn to normalized
eating patterns in BNeating patterns in BN
Future studies will testFuture studies will test
whether pharmacologicalwhether pharmacological
acceleration of gastricacceleration of gastric
emptying diminishes theemptying diminishes the
frequency and size of bingefrequency and size of binge
episodes among BN patientsepisodes among BN patients

Más contenido relacionado

La actualidad más candente

Intragsatric balloon back to the future
Intragsatric balloon  back to the futureIntragsatric balloon  back to the future
Intragsatric balloon back to the futureHossam Ghoneim
 
GIT j club motility women.
GIT j club motility women.GIT j club motility women.
GIT j club motility women.Shaikhani.
 
GIT j club IBS women.
GIT j club IBS women.GIT j club IBS women.
GIT j club IBS women.Shaikhani.
 
Presentation IBS & GERD
Presentation IBS & GERDPresentation IBS & GERD
Presentation IBS & GERDckapaale
 
What is Irritable Bowel Syndrome?
What is Irritable Bowel Syndrome?What is Irritable Bowel Syndrome?
What is Irritable Bowel Syndrome?alizain416
 
Mamagement competition
Mamagement competitionMamagement competition
Mamagement competitionhaithamo
 
Corazziari E. La Stipsi. ASMaD 2016
Corazziari E. La Stipsi. ASMaD 2016Corazziari E. La Stipsi. ASMaD 2016
Corazziari E. La Stipsi. ASMaD 2016Gianfranco Tammaro
 
Ianiro G. La Malattia Celiaca. ASMaD 2016
Ianiro G. La Malattia Celiaca. ASMaD 2016Ianiro G. La Malattia Celiaca. ASMaD 2016
Ianiro G. La Malattia Celiaca. ASMaD 2016Gianfranco Tammaro
 
GIT j club obesity women.
GIT j club obesity women.GIT j club obesity women.
GIT j club obesity women.Shaikhani.
 
Intragastric Balloons for Treatment of Obesity
Intragastric Balloons for Treatment of ObesityIntragastric Balloons for Treatment of Obesity
Intragastric Balloons for Treatment of ObesityHossam Ghoneim
 
GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011Shaikhani.
 
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Monkez M Yousif
 
Irritable bowel syndrome
Irritable bowel syndromeIrritable bowel syndrome
Irritable bowel syndromerahna666
 
GIT 4th IBS 2017
GIT 4th IBS 2017GIT 4th IBS 2017
GIT 4th IBS 2017Shaikhani.
 
Novick b358 apt_nov02
Novick b358 apt_nov02Novick b358 apt_nov02
Novick b358 apt_nov02haithamo
 
Irritable Bowel Disease
Irritable Bowel DiseaseIrritable Bowel Disease
Irritable Bowel DiseaseRakesh Kumar
 
Irritable Bowel Syndrome
Irritable Bowel SyndromeIrritable Bowel Syndrome
Irritable Bowel SyndromePV. Viji
 

La actualidad más candente (20)

Intragsatric balloon back to the future
Intragsatric balloon  back to the futureIntragsatric balloon  back to the future
Intragsatric balloon back to the future
 
GIT j club motility women.
GIT j club motility women.GIT j club motility women.
GIT j club motility women.
 
GIT j club IBS women.
GIT j club IBS women.GIT j club IBS women.
GIT j club IBS women.
 
Presentation IBS & GERD
Presentation IBS & GERDPresentation IBS & GERD
Presentation IBS & GERD
 
What is Irritable Bowel Syndrome?
What is Irritable Bowel Syndrome?What is Irritable Bowel Syndrome?
What is Irritable Bowel Syndrome?
 
Mamagement competition
Mamagement competitionMamagement competition
Mamagement competition
 
Corazziari E. La Stipsi. ASMaD 2016
Corazziari E. La Stipsi. ASMaD 2016Corazziari E. La Stipsi. ASMaD 2016
Corazziari E. La Stipsi. ASMaD 2016
 
Ibs
IbsIbs
Ibs
 
Ianiro G. La Malattia Celiaca. ASMaD 2016
Ianiro G. La Malattia Celiaca. ASMaD 2016Ianiro G. La Malattia Celiaca. ASMaD 2016
Ianiro G. La Malattia Celiaca. ASMaD 2016
 
GIT j club obesity women.
GIT j club obesity women.GIT j club obesity women.
GIT j club obesity women.
 
Intragastric Balloons for Treatment of Obesity
Intragastric Balloons for Treatment of ObesityIntragastric Balloons for Treatment of Obesity
Intragastric Balloons for Treatment of Obesity
 
GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011
 
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
 
Irritable bowel syndrome
Irritable bowel syndromeIrritable bowel syndrome
Irritable bowel syndrome
 
GIT 4th IBS 2017
GIT 4th IBS 2017GIT 4th IBS 2017
GIT 4th IBS 2017
 
Aspectos paar decidir una conversión
Aspectos paar decidir una conversiónAspectos paar decidir una conversión
Aspectos paar decidir una conversión
 
Clinical cases
Clinical casesClinical cases
Clinical cases
 
Novick b358 apt_nov02
Novick b358 apt_nov02Novick b358 apt_nov02
Novick b358 apt_nov02
 
Irritable Bowel Disease
Irritable Bowel DiseaseIrritable Bowel Disease
Irritable Bowel Disease
 
Irritable Bowel Syndrome
Irritable Bowel SyndromeIrritable Bowel Syndrome
Irritable Bowel Syndrome
 

Similar a SSIB-2002

Gastric & Duodenal Release of Cholecystokinin
Gastric & Duodenal Release of CholecystokininGastric & Duodenal Release of Cholecystokinin
Gastric & Duodenal Release of CholecystokininDr. Janet Guss Darwich
 
Small bowel obstruction/ Generalised abdominal pain
Small bowel obstruction/  Generalised abdominal painSmall bowel obstruction/  Generalised abdominal pain
Small bowel obstruction/ Generalised abdominal painSelvaraj Balasubramani
 
Linzela Disease part chronic idiopathic constipation.pptx
Linzela Disease part chronic idiopathic constipation.pptxLinzela Disease part chronic idiopathic constipation.pptx
Linzela Disease part chronic idiopathic constipation.pptxKhaledEbneAbdullahRe
 
Biological Aspects Of Obesity Related Eating Disorders111
Biological Aspects Of Obesity Related Eating Disorders111Biological Aspects Of Obesity Related Eating Disorders111
Biological Aspects Of Obesity Related Eating Disorders111VeoMed
 
Obstructed defecation syndrome
Obstructed defecation syndromeObstructed defecation syndrome
Obstructed defecation syndromeApollo Hospitals
 
GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.Shaikhani.
 
Drs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: June Cases
Drs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: June CasesDrs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: June Cases
Drs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: June CasesSean M. Fox
 
Acs0516 Motility Disorders 2005
Acs0516 Motility Disorders 2005Acs0516 Motility Disorders 2005
Acs0516 Motility Disorders 2005medbookonline
 
Amer famphysgallstones
Amer famphysgallstonesAmer famphysgallstones
Amer famphysgallstonesSameh Naguib
 
GITj club bloating.
GITj club bloating.GITj club bloating.
GITj club bloating.Shaikhani.
 
Knmp congres 4okt-1500u-marc benninga
Knmp congres 4okt-1500u-marc benningaKnmp congres 4okt-1500u-marc benninga
Knmp congres 4okt-1500u-marc benningaKNMP
 
1-nutritionalsupportinthesurgicalpatient-091018231233-phpapp01.pdf
1-nutritionalsupportinthesurgicalpatient-091018231233-phpapp01.pdf1-nutritionalsupportinthesurgicalpatient-091018231233-phpapp01.pdf
1-nutritionalsupportinthesurgicalpatient-091018231233-phpapp01.pdfUsaidSulaiman1
 
Gastrointestinal disorders
Gastrointestinal disordersGastrointestinal disorders
Gastrointestinal disordersEmily Riegel
 
Stato dell'arte nello studio del Microbiota
Stato dell'arte nello studio del MicrobiotaStato dell'arte nello studio del Microbiota
Stato dell'arte nello studio del MicrobiotaASMaD
 
Surgeons' Confusion & Misunderstanding the MGB: Bile, Bile Reflux, Bile Reflu...
Surgeons' Confusion &Misunderstanding the MGB:Bile, Bile Reflux, Bile Reflu...Surgeons' Confusion &Misunderstanding the MGB:Bile, Bile Reflux, Bile Reflu...
Surgeons' Confusion & Misunderstanding the MGB: Bile, Bile Reflux, Bile Reflu...Dr. Robert Rutledge
 

Similar a SSIB-2002 (20)

Gastric & Duodenal Release of Cholecystokinin
Gastric & Duodenal Release of CholecystokininGastric & Duodenal Release of Cholecystokinin
Gastric & Duodenal Release of Cholecystokinin
 
Small bowel obstruction/ Generalised abdominal pain
Small bowel obstruction/  Generalised abdominal painSmall bowel obstruction/  Generalised abdominal pain
Small bowel obstruction/ Generalised abdominal pain
 
Linzela Disease part chronic idiopathic constipation.pptx
Linzela Disease part chronic idiopathic constipation.pptxLinzela Disease part chronic idiopathic constipation.pptx
Linzela Disease part chronic idiopathic constipation.pptx
 
Linaclotide
LinaclotideLinaclotide
Linaclotide
 
Biological Aspects Of Obesity Related Eating Disorders111
Biological Aspects Of Obesity Related Eating Disorders111Biological Aspects Of Obesity Related Eating Disorders111
Biological Aspects Of Obesity Related Eating Disorders111
 
Obstructed defecation syndrome
Obstructed defecation syndromeObstructed defecation syndrome
Obstructed defecation syndrome
 
GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.
 
Drs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: June Cases
Drs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: June CasesDrs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: June Cases
Drs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: June Cases
 
Acs0516 Motility Disorders 2005
Acs0516 Motility Disorders 2005Acs0516 Motility Disorders 2005
Acs0516 Motility Disorders 2005
 
Amer famphysgallstones
Amer famphysgallstonesAmer famphysgallstones
Amer famphysgallstones
 
GITj club bloating.
GITj club bloating.GITj club bloating.
GITj club bloating.
 
Length of roux
Length of rouxLength of roux
Length of roux
 
Overactive Bladder.
Overactive Bladder.Overactive Bladder.
Overactive Bladder.
 
Knmp congres 4okt-1500u-marc benninga
Knmp congres 4okt-1500u-marc benningaKnmp congres 4okt-1500u-marc benninga
Knmp congres 4okt-1500u-marc benninga
 
1-nutritionalsupportinthesurgicalpatient-091018231233-phpapp01.pdf
1-nutritionalsupportinthesurgicalpatient-091018231233-phpapp01.pdf1-nutritionalsupportinthesurgicalpatient-091018231233-phpapp01.pdf
1-nutritionalsupportinthesurgicalpatient-091018231233-phpapp01.pdf
 
Gastrointestinal disorders
Gastrointestinal disordersGastrointestinal disorders
Gastrointestinal disorders
 
Stato dell'arte nello studio del Microbiota
Stato dell'arte nello studio del MicrobiotaStato dell'arte nello studio del Microbiota
Stato dell'arte nello studio del Microbiota
 
Surgeons' Confusion & Misunderstanding the MGB: Bile, Bile Reflux, Bile Reflu...
Surgeons' Confusion &Misunderstanding the MGB:Bile, Bile Reflux, Bile Reflu...Surgeons' Confusion &Misunderstanding the MGB:Bile, Bile Reflux, Bile Reflu...
Surgeons' Confusion & Misunderstanding the MGB: Bile, Bile Reflux, Bile Reflu...
 
Chron's Case Study
Chron's Case StudyChron's Case Study
Chron's Case Study
 
Dr Arun Aggarwal Gastreontologist on ANMS
Dr Arun Aggarwal Gastreontologist on ANMSDr Arun Aggarwal Gastreontologist on ANMS
Dr Arun Aggarwal Gastreontologist on ANMS
 

Último

CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumassuser144901
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...ocean4396
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...marcuskenyatta275
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUELMKARTHIKEMMANUEL
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifierNidhi Joshi
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1DR SETH JOTHAM
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...marcuskenyatta275
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxDr. Rabia Inam Gandapore
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor rawSherrylee83
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadNephroTube - Dr.Gawad
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptdesktoppc
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenRaju678948
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingMedicoseAcademics
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptxdr shahida
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materialsSherrylee83
 

Último (20)

CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
 

SSIB-2002

  • 1. Normalization of Delayed GastricNormalization of Delayed Gastric Emptying after Treatment forEmptying after Treatment for Bulimia NervosaBulimia Nervosa Janet L. Guss, BT Walsh, HR Kissileff, EJanet L. Guss, BT Walsh, HR Kissileff, E Zimmerli, R Sysko & MJ DevlinZimmerli, R Sysko & MJ Devlin Obesity Research CenterObesity Research Center Columbia UniversityColumbia University
  • 2. Patients with Bulimia Nervosa (BN) have aPatients with Bulimia Nervosa (BN) have a disturbance in the development of satiety:disturbance in the development of satiety: Episodes of uncontrolled hyperphagiaEpisodes of uncontrolled hyperphagia Rates of eating do not decline as meal progressesRates of eating do not decline as meal progresses More food required to increase ratings of fullnessMore food required to increase ratings of fullness Blunted post-prandial cholecystokinin (CCK) releaseBlunted post-prandial cholecystokinin (CCK) release
  • 3. Gastric Emptying may be delayed in BN:Gastric Emptying may be delayed in BN: Authors Delayed Emptying?Authors Delayed Emptying? CommentsComments Shih et al, 1987Shih et al, 1987 Yes (12/20) other 8/20 acceleratedYes (12/20) other 8/20 accelerated Robinson et al, 1988Robinson et al, 1988 No (1/10)No (1/10) Cuellar et al, 1988Cuellar et al, 1988 Yes (2/5)Yes (2/5) only pts with GI symptomsonly pts with GI symptoms Hutson & Wald, 1990Hutson & Wald, 1990 NoNo Geliebter et al, 1992Geliebter et al, 1992 Yes /NoYes /No only @ 5 & 15 minonly @ 5 & 15 min Inui et al, 1995Inui et al, 1995 YesYes small number of subjectssmall number of subjects Devlin et al, 1997Devlin et al, 1997 Yes/NoYes/No delayed in 1 of 3 conditionsdelayed in 1 of 3 conditions
  • 4. HypothesisHypothesis Satiety disturbances in patients with BN maySatiety disturbances in patients with BN may be perpetuated by delayed gastric emptyingbe perpetuated by delayed gastric emptying Delayed emptying may blunt nutrient-Delayed emptying may blunt nutrient- triggered release of gut peptides, such astriggered release of gut peptides, such as CCK, that normally bring about satiationCCK, that normally bring about satiation
  • 5. PurposePurpose Confirm previous reports of delayed gastricConfirm previous reports of delayed gastric emptying among patients with BNemptying among patients with BN Determine whether disturbance normalizesDetermine whether disturbance normalizes after cessation of binge & purge behaviorsafter cessation of binge & purge behaviors
  • 6. ProcedureProcedure Subjects:Subjects: 16 patients meeting DSM-IV criteria for BN16 patients meeting DSM-IV criteria for BN 16 demographically-matched controls16 demographically-matched controls 9 of the 16 patients retested, if they abstained from9 of the 16 patients retested, if they abstained from bulimic behaviors for at least 4 weeksbulimic behaviors for at least 4 weeks Procedure:Procedure: Emptying ofEmptying of 99m99m TcDTPA-labeled Ensure Plus (600g, 950TcDTPA-labeled Ensure Plus (600g, 950 kcal) monitored via gamma scintigraphykcal) monitored via gamma scintigraphy Counts collected at 2-min intervals for 90 minutesCounts collected at 2-min intervals for 90 minutes Counts determined within defined region of interestCounts determined within defined region of interest (ROI) and converted to percentage of maximum counts(ROI) and converted to percentage of maximum counts
  • 7. Experimental TimelineExperimental Timeline PositionPosition SSubjectubject StartStart GammaGamma CameraCamera 600 g600 g EnsureEnsure PlusPlus Stop GammaStop Gamma CameraCamera Radioactive counts acquired every 2 min for 90 min PositionPosition SubjectSubject
  • 8. Subject Characteristics:Subject Characteristics: (Mean(Mean  SE)SE) ControlsControls PatientsPatients nn 1616 1616 Age (yrs)Age (yrs) 26.826.8 ±± 1.01.0 24.224.2 ±± 1.11.1 Weight (kg)Weight (kg) 62.262.2 ±± 1.51.5 59.459.4 ±± 1.91.9 Height (m)Height (m) 1.71.7 ±± 0.020.02 1.61.6 ±± 0.020.02 BMI (kg/m2)BMI (kg/m2) 21.721.7 ±± 0.40.4 22.122.1 ±± 0.70.7
  • 9. Clinical Characteristics (MeanClinical Characteristics (Mean  SE)SE) ControlsControls PatientsPatients DifferenceDifference RestraintRestraint 6.56.5  5.75.7 13.713.7  4.74.7 p<.005p<.005 DisinhibitionDisinhibition 3.03.0  1.11.1 13.313.3  2.02.0 p<.001p<.001 HungerHunger 3.53.5  2.02.0 10.010.0  3.33.3 p<.001p<.001 Duration (yrs)Duration (yrs) ---- 11.311.3  7.57.5 Binges/wkBinges/wk ---- 18.218.2  27.727.7 Vomiting/wkVomiting/wk ---- 20.420.4  17.717.7
  • 10. Data AnalysisData Analysis Patients versus Controls: t-testsPatients versus Controls: t-tests Amount emptied (g) over 90 minutesAmount emptied (g) over 90 minutes Rate (g/min)Rate (g/min) Patients, Pre versus Post Treatment: paired t-testsPatients, Pre versus Post Treatment: paired t-tests Amount emptied over 90 minutesAmount emptied over 90 minutes Rate (g/min)Rate (g/min)
  • 11. Gastric Emptying: Patients vs ControlsGastric Emptying: Patients vs Controls Time (min) 0 10 20 30 40 50 60 70 80 90 PercentofInitialRemaining 40 50 60 70 80 90 100 Bulimia Nervosa Controls
  • 12. Gastric Emptying: Pre vs Post Treatment Time (min) 0 10 20 30 40 50 60 70 80 90 PercentageofInitialRemaining 40 50 60 70 80 90 100 Pretreatment Post-treatment
  • 13. Amount Emptied over 90 MinutesAmount Emptied over 90 Minutes Bulimic Control Pre-Tx Post-Tx AmountEmptied(g) 0 50 100 150 200 250 300 350 Patients v p < 0.001 P < 0.001P < 0.001 P < 0.01P < 0.01
  • 14. Bulimic Control Pre-Tx Post-Tx EmptyingRate(g/min) 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 Patients Gastric Emptying Rate (g/min)Gastric Emptying Rate (g/min) P < 0.01P < 0.01 P < 0.05P < 0.05
  • 15. SummarySummary Patients with BN exhibited reducedPatients with BN exhibited reduced gastric emptying which improvedgastric emptying which improved significantly after termination ofsignificantly after termination of binge/purge activitybinge/purge activity
  • 16. ConclusionsConclusions Normalization of gastricNormalization of gastric emptying mayemptying may mediatemediate,, oror be mediated bybe mediated by, a, a return to normalizedreturn to normalized eating patterns in BNeating patterns in BN Future studies will testFuture studies will test whether pharmacologicalwhether pharmacological acceleration of gastricacceleration of gastric emptying diminishes theemptying diminishes the frequency and size of bingefrequency and size of binge episodes among BN patientsepisodes among BN patients

Notas del editor

  1. The following observations have led us to hypothesize that patients with BN have a satiety deficiency
  2. Significantly less of the drink remained in patients’ stomachs after treatment than before (n = 9, mean = 14.5% ± 3.5 SE, t = 4.14, P = 0.014). The emptying rate improved by .99 g/min (± 0.24 SED; t = 4.14, P = 0.01), from a mean of 2.27 g/min ( ± 0.11 SE), to a mean of 3.14 g/min (± 0.17 SE).